Stefano Zannella
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Stefano Zannella has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Giorgio Cattoretti
Pathology, Department of Medicine and Surgery, Universitá di Milano-Bicocca, Monza, Michigan, Italy
1 shared publication Giuseppe Pelosi
Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy Università degli Studi di Milano, Milan, Italy
1 shared publication- Maria Adele Testi
Department of Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
1 shared publication - Nicola Zucchini
Department of Medicine and Surgery, Pathology, Fondazione IRCCS San Gerardo dei Tintori, Università di Milano-Bicocca, Monza, Italy
1 shared publication
Latest Publications
- 28 January 2014
- Published by SAGE Publications in International Journal of Surgical Pathology
- Vol. 22 (6) , 552-554
Peritoneal Malignant Mesothelioma Metastatic to Supraclavicular Lymph Nodes
Distinguishing between malignant mesothelioma and reactive mesothelial hyperplasia is often inestimable, but may be a challenging gauntlet for pathologists. A 62-year-old man underwent appendectomy after the identification of a peritoneal mass and the histological examination showed mesothelial proliferation along the appendix surface with no clear images of infiltration. After a few months the patient developed mediastinal and supraclavicular lymphadenopathies, and a nodal biopsy showed mesothelial cell proliferation invading lymphatic sinuses, consistent with the cells seen in the abdominal cavity. Since overt morphologic criteria for malignancy were lacking and reactive mesothelial cell deposits have been documented in lymph nodes, a molecular investigation of the CDKN2A (henceforth simply p16) gene status via fluorescence in situ hybridization was performed, which showed homozygous deletion in 100% tumor cells. These data ruled out the hypothesis of reactive mesothelial cells inclusion in lymph nodes, thus confirming the diagnosis of epithelioid malignant mesothelioma.
- 28 January 2014
- Published by SAGE Publications in International Journal of Surgical Pathology
- Vol. 22 (6) , 552-554
Peritoneal Malignant Mesothelioma Metastatic to Supraclavicular Lymph Nodes
Distinguishing between malignant mesothelioma and reactive mesothelial hyperplasia is often inestimable, but may be a challenging gauntlet for pathologists. A 62-year-old man underwent appendectomy after the identification of a peritoneal mass and the histological examination showed mesothelial proliferation along the appendix surface with no clear images of infiltration. After a few months the patient developed mediastinal and supraclavicular lymphadenopathies, and a nodal biopsy showed mesothelial cell proliferation invading lymphatic sinuses, consistent with the cells seen in the abdominal cavity. Since overt morphologic criteria for malignancy were lacking and reactive mesothelial cell deposits have been documented in lymph nodes, a molecular investigation of the CDKN2A (henceforth simply p16) gene status via fluorescence in situ hybridization was performed, which showed homozygous deletion in 100% tumor cells. These data ruled out the hypothesis of reactive mesothelial cells inclusion in lymph nodes, thus confirming the diagnosis of epithelioid malignant mesothelioma.